Gender differences in care for acquired immunodeficiency syndrome - Related Pneumocystis carinii pneumonia

Women's Health Issues

Volumn 8, Issue 1, 1998, Pages 45-52

  Bastian, Lori A ^a   Sloane, Richard J ^b   DeHovitz, Jack A ^c   Bennett, Charles L ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATTITUDE; BRONCHOSCOPY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PNEUMOCYSTIS PNEUMONIA; SEX DIFFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; BRONCHOSCOPY; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; EVALUATION STUDIES; FEMALE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; INSURANCE COVERAGE; MALE; MEDICAID; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS; PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF HEALTH CARE; RISK-TAKING; SEVERITY OF ILLNESS INDEX; SEX; SUBSTANCE ABUSE, INTRAVENOUS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UNITED STATES; ZIDOVUDINE;

EID: 0031907563     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1049-3867(97)00073-X     Document Type: Article

References (37)

1. 1. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 1995. Atlanta: U.S. Department of Health and Human Services, Public Health Service, Vol 7, No 2, 1996.
2. 2. Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL. Gender differences in reported AIDS-indicative diagnoses. J Infect Dis 1993;168:61-7.
3. 3. Bastian LA, Bennett CL, Adams J, Waskins H, Edlin BR. Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:617-623.
4. 4. Carpenter CC, Mayer KH, Fisher A, Desai MD. Natural history of acquired immunodeficiency in women in Rhode Island. Am J Med 1989;86:771-5.
5. 5. Carpenter CC, Mayer KH, Stein MD, Leibman BD, Fisher A, Fiore TC. HIV infection in North American women: experience with 200 cases and a review of the literature. Medicine 1991;70:307-25.
6. 6. Melnick SL, Wertheimer WJ, Pinn VW. Women and HIV/AIDS research in the United States. J Am Med Women Assoc 1995;50:137-8.
7. 7. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. New Engl J Med 1993;329:1922-6.
8. 8. Melnick SL, Sherer R, Louis TA, et al. Survival and disease progression according to gender of patients with HIV infection. JAMA 1994;272:1915-21.
9. 9. Piette J, Mor V, Fleishman J. Patterns of survival with AIDS in the United States. Health Serv Res 1991;26:77-95.
10. 10. Rothenberg R, Woelfel M, Stoneburner R, et al. Survival with the acquired immunodeficiency syndrome. New Engl J Med 1987;317:1297-302.
11. 11. Friedland GH, Saltzman B, Vileno J, et al. Survival differences in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1991;4:144-53.
12. 12. Lemp GF, Payne SF, Neal D, Temlso T, Rutherford GW. Survival trends for patients with AIDS. JAMA 1990;263:402-6.
13. 13. Bennett CL, Kosecoff J, Kanouse D. Results of a consensus panel on process of care for patients hospitalized with PCP [abstract]. Presented at the Fifth International Conference on AIDS, Montreal, Quebec, June 1989.
14. 14. Oken C, Archibald N, Cvitanic M, et al. Multi-city study of quality of care for HIV-related PCP: successfully collecting highly sensitive information. Clin Perf Qual Health Care 1995;3:140-6.
15. 15. Bennett CL, Horner RD, Weinstein RA et al. Racial differences in care among hospitalized patients with PCP in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. Arch Intern Med 1995;155:1586-92.
16. 16. Bennett Cl, Weinstein RA, Shapiro MF, Kessler HA, et al. A rapid pre-admission method for predicting inpatient course of disease for patients with HIV-related PCP. Am J Resp Crit Care 1994;150:1503-7.
17. 17. Keitz SA, Bastian LA, Bennett CL, Oddone EZ, DeHovitz JA, Weinstein RA. AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med 1996;11:591-6.
18. 18. Bennett CL, Roth CP, Iqbal A, et al. Medical record abstraction form and guidelines for assessing quality of care for hospitalized patients with AIDS-related Pneumocystis carinii pneumonia. A RAND Note, N-3549-AHCPR, 1993.
19. 19. Fleiss JL. Statistical methods for rates and proportions, 2d ed. New York: John Wiley & Sons, 1981:260-80.
20. 20. Bennett CL, Cassileth BR, DeHovitz JA, Weinstein RA. Score cards for AIDS care. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:286-90.
21. 21. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ 1995;311:793-6.
22. 22. Park RE, Brook RH, Kosekoff J, et al. Explaining variations in hospital death rates: randomness, severity of illness, quality of care. JAMA 1990;264:484-90.
23. 23. Meehan TP, Hennen J, Radford MJ, et al. Process and outcome of care for acute myocardial infarction among medicare beneficiaries in Connecticut: a quality improvement demonstration project. Ann Intern Med 1995;122:928-36.
24. 24. Curtis JR, Ullman M, Collier AC, et al. Variations in medical care for HIV-related PCP: a comparison of process and outcomes at two hospitals. Chest 1997;112:398-405.
25. 25. Horner RD, Bennett CL, Weinstein RA, et al. Relationship between procedures and health insurance for critically ill patients with PCP. Am J Resp Crit Care Med 1995;152:1435-42.
26. 26. Bennett CL, Ullman M, Dickinson GM, et al. Patterns of care for HIV-related PCP in a university medical program: a case study. Clin Perf Qual Health care 1996;4: 186-9.
27. 27. Hellinger FJ. The use of health services by women with HIV infection. Health Serv Res 1993;28:5:534-61.
28. 28. Moore RD, Hidalgo J, Bareta JC, Chaisson RE. Zidovudine therapy and health resource utilization in AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:349-54.
29. 29. Moore RD, Hidalgo J, Sugland BW, Chaisson RE. Zidovudine and the natural history of the acquired immunodeficiency syndrome. New Engl J Med 1991;324: 1412-6.
30. 30. Lagakos S, Fischl MA, Strein DS, Lim L, Volberding P. Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. JAMA 1991;266: 2709-12.
31. 31. Turner BJ, Markson LE, McKee LJ, Houchens R, Fanning T. Health care delivery zidovudine use, and survival of women and men with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:1250-62.
32. 32. Sha BE, Benson CA, Pottage JC, et al. HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago. Acquir Immune Defic Syndr Hum Retrovirol 1995;8:486-95.
33. 33. Chaisson Re, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. New Engl J Med 1995;333:751-6.
34. 34. Stone VE, Mauch MY, Steger K, Janas SF, Craven DE. Race, gender, drug use, and participation in AIDS clinical trials: lessons from a municipal hospital cohort. J Gen Intern Med 1997;12:150-7.
35. 35. Buehler JW, Ward JW, Berkelman RL. The surveillance definition for AIDS in the United States. AIDS 1993;7:585-7.
36. 36. Centers for Disease Control and Prevention 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17);1-19.
37. 37. Schoenbaum EE, Webber MP. The underrecognition of HIV infection in women in an inner-city emergency room. Am J Public Health 1993;83:363-68.